Compared with vs DPP4 inhibitors, SGLT2 inhibitors reduce the risk for kidney and ureteral stones in patients with type 2 diabetes, including those with a stone history. Sodium-glucose cotransporter 2 ...

Despite weight loss and glycemic control, experts caution that type 2 diabetes remission is not a cure and that pancreatic ...

"For example, prior work among individuals undergoing cardiac surgery reported much higher rates of diabetic ketoacidosis among individuals taking SGLT2 inhibitors." "Going forward, findings from ...

The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people ...

However, among 14,665 matched pairs of GLP-1 agonist and SGLT2 inhibitor users ... interpreted with caution," the researchers said. For example, patients who consistently adhered to their ...

Adults with overweight or obesity and type 2 diabetes who are given the sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin alongside moderate calorie restriction achieve much higher ...

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

Type 2 diabetes is a global health challenge affecting more than 400 million adults. While it is often seen as a lifelong ...

For example, Roche introduced Accu-Chek SmartGuide ... Its diabetes portfolio features innovative treatments such as SGLT2 inhibitors (e.g., FORXIGA), GLP-1 receptor agonists (e.g., Bydureon ...

Tandem Diabetes Care, Inc. , a leading insulin delivery and diabetes technology company, today announced publication by The New England Journal of Medicine (NEJM) of positive results from the ...